Sahni, JN;
Czanner, G;
Gutu, T;
Taylor, SA;
Bennett, KM;
Wuerger, SM;
Grierson, I;
... Harding, SP; + view all
(2017)
Safety and acceptability of an organic light-emitting diode sleep mask as a potential therapy for retinal disease.
Eye
, 31
pp. 97-106.
10.1038/eye.2016.259.
Preview |
Text (Accepted manuscript)
Sahni_Safety_acceptability_organic_AAM.pdf - Accepted Version Download (523kB) | Preview |
Preview |
Text (Supplementary tables)
Sahni_Safety_acceptability_organic_AAM_Suppl.pdf - Accepted Version Download (114kB) | Preview |
Abstract
PURPOSE: The purpose of the study was to study the effect of an organic light-emitting diode sleep mask on daytime alertness, wellbeing, and retinal structure/function in healthy volunteers and in diabetic macular oedema (DMO). PATIENTS AND METHODS: Healthy volunteers in two groups, 18–30 yrs (A), 50–70 yrs (B) and people with DMO (C) wore masks (504 nm wavelength; 80 cd/m2 luminance; ≤8 h) nightly for 3 months followed by a 1-month recovery period. Changes from baseline were measured for (means): psychomotor vigilance task (PVT) (number of lapses (NL), response time (RT)), sleep, depression, psychological wellbeing (PW), visual acuity, contrast sensitivity, colour, electrophysiology, microperimetry, and retinal thickness on OCT. RESULTS: Of 60 participants, 16 (27%) withdrew, 8 (13%) before month 1, due to sleep disturbances and mask intolerance. About 36/55 (65%) who continued beyond month 1 reported ≥1 adverse event. At month 3 mean PVT worsened in Group A (RT (7.65%, P<0.001), NL (43.3%, P=0.005)) and mean PW worsened in all groups (A 28.0%, P=0.01, B 21.2%, P=0.03, C 12.8%, P<0.05). No other clinically significant safety signal was detected. Cysts reduced/resolved in the OCT subfield of maximal pathology in 67% Group C eyes. Thinning was greater at 3 and 4 months for greater baseline thickness (central subfield P<0.001, maximal P<0.05). CONCLUSION: Sleep masks showed no major safety signal apart from a small impairment of daytime alertness and a moderate effect on wellbeing. Masks were acceptable apart from in some healthy participants. Preliminary data suggest a beneficial effect on retinal thickness in DMO. This novel therapeutic approach is ready for large clinical trials.
| Type: | Article |
|---|---|
| Title: | Safety and acceptability of an organic light-emitting diode sleep mask as a potential therapy for retinal disease |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/eye.2016.259 |
| Publisher version: | http://dx.doi.org/10.1038/eye.2016.259 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10046520 |
Archive Staff Only
 |
View Item |
